These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 2880954)

  • 21. Multiple severe complications from recreational ingestion of MDMA ('Ecstasy').
    Brown C; Osterloh J
    JAMA; 1987 Aug; 258(6):780-1. PubMed ID: 2886672
    [No Abstract]   [Full Text] [Related]  

  • 22. Responses to i.v. L-tryptophan in MDMA users.
    Price LH; Ricaurte GA; Krystal JH; Heninger GR
    NIDA Res Monogr; 1989; 95():421-2. PubMed ID: 2577044
    [No Abstract]   [Full Text] [Related]  

  • 23. The complications of 'ecstasy' (MDMA).
    Verebey K; Alrazi J; Jaffe JH
    JAMA; 1988 Mar; 259(11):1649-50. PubMed ID: 2893845
    [No Abstract]   [Full Text] [Related]  

  • 24. A bit on the Wilde side: MDMA abuse.
    Mack RB
    N C Med J; 1985 Dec; 46(12):641-2. PubMed ID: 2867475
    [No Abstract]   [Full Text] [Related]  

  • 25. "Ecstasy" (MDMA)-induced panic.
    Whitaker-Azmitia PM; Aronson TA
    Am J Psychiatry; 1989 Jan; 146(1):119. PubMed ID: 2563207
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of the behavioral and neurochemical effects of 5,7-DHT, MDMA and D,L-fenfluramine.
    Lorens SA; Hata N; Cabrera T; Hamilton ME
    NIDA Res Monogr; 1989; 95():347. PubMed ID: 2577039
    [No Abstract]   [Full Text] [Related]  

  • 27. Studies of MDMA-induced neurotoxicity in nonhuman primates: a basis for evaluating long-term effects in humans.
    Ricaurte GA
    NIDA Res Monogr; 1989; 94():306-22. PubMed ID: 2575227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An exploration of the history and controversies surrounding MDMA and MDA.
    Pentney AR
    J Psychoactive Drugs; 2001; 33(3):213-21. PubMed ID: 11718314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in the stimulus properties of 3,4-methylenedioxyamphetamine and 3,4- methylenedioxymethamphetamine in animals trained to discriminate hallucinogens from saline.
    Callahan PM; Appel JB
    J Pharmacol Exp Ther; 1988 Sep; 246(3):866-70. PubMed ID: 2901488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 3,4-Methylenedioxymethamphetamine (MDMA) and other amphetamine derivatives.
    Bost RO
    J Forensic Sci; 1988 Mar; 33(2):576-87. PubMed ID: 2897421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A case of MAO inhibitor/MDMA interaction: agony after ecstasy.
    Smilkstein MJ; Smolinske SC; Rumack BH
    J Toxicol Clin Toxicol; 1987; 25(1-2):149-59. PubMed ID: 2884326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Studies on the identification of psychotropic substances (VII). Preparation and various analytical data of standard references of some hallucinogens, 3,4-methylenedioxyamphetamine (MDA), 3,4- methylenedioxymethamphetamine (MDMA) and 5-methoxy-3,4- methylenedioxyamphetamine (MMDA)].
    Shimamine M; Takahashi K; Nakahara Y
    Eisei Shikenjo Hokoku; 1990; (108):118-25. PubMed ID: 1364339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 3,4-Methylenedioxymethamphetamine ("ecstasy") selectively destroys brain serotonin terminals in rhesus monkeys.
    Insel TR; Battaglia G; Johannessen JN; Marra S; De Souza EB
    J Pharmacol Exp Ther; 1989 Jun; 249(3):713-20. PubMed ID: 2471824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ["Ecstasy" and "ice": the return of the amphetamines].
    Kaminer Y; Zemishlany Z
    Harefuah; 1991 Jun; 120(12):727-9. PubMed ID: 1683637
    [No Abstract]   [Full Text] [Related]  

  • 35. Behavioral and neurochemical effects of orally administered MDMA in the rodent and nonhuman primate.
    Slikker W; Holson RR; Ali SF; Kolta MG; Paule MG; Scallet AC; McMillan DE; Bailey JR; Hong JS; Scalzo FM
    Neurotoxicology; 1989; 10(3):529-42. PubMed ID: 2576304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increasing use of "Ecstasy" (MDMA) and other hallucinogens on a college campus.
    Cuomo MJ; Dyment PG; Gammino VM
    J Am Coll Health; 1994 May; 42(6):271-4. PubMed ID: 7913938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ecstasy returns to Schedule I.
    Barnes DM
    Science; 1988 Apr; 240(4848):24. PubMed ID: 2895498
    [No Abstract]   [Full Text] [Related]  

  • 38. The state of Ecstasy: MDMA--science and policy.
    Heilig S
    J Psychoactive Drugs; 2002; 34(2):129-31. PubMed ID: 12691201
    [No Abstract]   [Full Text] [Related]  

  • 39. Meetings at the edge with Adam: a man for all seasons?
    Wolfson PE
    J Psychoactive Drugs; 1986; 18(4):329-33. PubMed ID: 2880947
    [No Abstract]   [Full Text] [Related]  

  • 40. New method to monitor drugs at dance venues. Perhaps results of testing tablets should be made public.
    Cole J
    BMJ; 2002 Feb; 324(7332):299; author reply 299. PubMed ID: 11823374
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.